Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
75%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (75.0%)
Phase 31 (25.0%)

Trials by Status

completed250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_2

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

NCT00002715
unknownphase_3

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

NCT00041210
unknownphase_2

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

NCT00003262
completedphase_2

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease

NCT00002714

Clinical Trials (4)

Showing 4 of 4 trials
NCT00002715Phase 2

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

Completed
NCT00041210Phase 3

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

Unknown
NCT00003262Phase 2

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

Unknown
NCT00002714Phase 2

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4